In breast cancer and prostate cancers, ZMYND8 has been reported as a tumor suppressor that cooperates with the histone demethylases, KDM5 family functions to remove methyl group from the mark H3K4me3, such as KDM5C [110, 125]. Here, ZMYND8 is linked to prostate carcinoma.